drugset / Trial / NCT00456924
Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the present study is to evaluate continuous administration of low doses of VA2914 for potential contraceptive activity and effects on the menstrual cycle and steroid hormone parameters.
Timeline
- Start
- 2004-01
- Primary completion
- —
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ulipristal Acetate | Unknown | 2.5 mg | — |
| Subject | Ulipristal Acetate | Unknown | 5 mg | — |
| Subject | Ulipristal Acetate | Unknown | 10 mg | — |